Kuwait Spine Biologics Market Size & Outlook, 2023-2030

The spine biologics market in Kuwait is expected to reach a projected revenue of US$ 7.3 million by 2030. A compound annual growth rate of 3.8% is expected of Kuwait spine biologics market from 2024 to 2030.
Revenue, 2023 (US$M)
$5.6
Forecast, 2030 (US$M)
$7.3
CAGR, 2024 - 2030
3.8%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait spine biologics market, 2018-2030 (US$M)

Kuwait spine biologics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait spine biologics market highlights

  • The Kuwait spine biologics market generated a revenue of USD 5.6 million in 2023 and is expected to reach USD 7.3 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
  • In terms of segment, spinal allografts was the largest revenue generating product in 2023.
  • Cell-based Matrix is the most lucrative product segment registering the fastest growth during the forecast period.


Spine biologics market data book summary

Market revenue in 2023USD 5.6 million
Market revenue in 2030USD 7.3 million
Growth rate3.8% (CAGR from 2023 to 2030)
Largest segmentSpinal allografts
Fastest growing segmentCell-based Matrix
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSpinal Allografts, Bone Graft Substitutes, Cell-based Matrix
Key market players worldwideStryker Corp, NuVasive, Orthofix Medical Inc, DePuy Synthes, Exactech, Zimmer Biomet Holdings Inc, Arthrex, Medtronic PLC, Organogenesis, Kuros Biosciences Ltd


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.2% of the global spine biologics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa spine biologics market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 17.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Spine Biologics Market Companies

Name Profile # Employees HQ Website
Kuros Biosciences Ltd View profile 80 Wagistrasse 25, Schlieren, Zurich, Switzerland, 8952 https://www.kurosbio.com
Exactech View profile 501-1000 Gainesville, Florida, United States, North America http://www.exac.com
Organogenesis View profile 501-1000 Canton, Massachusetts, United States, North America http://www.organogenesis.com/
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
Orthofix Medical Inc View profile 1634 3451 Plano Parkway, Lewisville, TX, United States, 75056 https://www.orthofix.com
NuVasive View profile 1001-5000 San Diego, California, United States, North America http://www.nuvasive.com
DePuy Synthes View profile 5001-10000 Raynham, Massachusetts, United States, North America https://depuysynthes.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com

Kuwait spine biologics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to spine biologics market will help companies and investors design strategic landscapes.


Spinal allografts was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the Kuwait spine biologics market based on spinal allografts, bone graft substitutes, cell-based matrix covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Kuwait spine biologics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait spine biologics market databook

  • Our clientele includes a mix of spine biologics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait spine biologics market, including forecasts for subscribers. This country databook contains high-level insights into Kuwait spine biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait spine biologics market size, by product, 2018-2030 (US$M)

Kuwait Spine Biologics Market Share, 2023 & 2030 (US$M)

Kuwait spine biologics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online